Keine Ergebnisse gefunden
Die angefragte Seite konnte nicht gefunden werden. Verfeinern Sie Ihre Suche oder verwenden Sie die Navigation oben, um den Beitrag zu finden.
Christine Dawczynski, Gerhard Jahreis, Jena
In two interventional studies in man, the influence of the consumption of n-3-LC-PUFA-enriched yoghurt was examined on cardiovascular risk factors . The volunteers consumed the intervention products with 0.8 g n-3-LC-PUFA/125 g yoghurt or comparator products for a period of 5 or 10 weeks. Blood samples were taken at the start and end of each phase.As a consequence of the 5-week consumption of the enriched products, HDL-cholesterol was significantly increased and the LDL/HDL quotient was reduced. After 10 weeks, these effects were more marked in the group given 0.8 g n-3-LC-PUFA/125 g yoghurt. The favourable changes in HDL-cholesterol and in the LDL/HDL quotient were not found in subjects given low fat (less enriched) yoghurt over a period of 10 weeks.
There was a trend for TAG to be reduced in this group (p ≤ 0.1). Conclusion: Daily consumption of n-3-LC-PUFA-enriched yoghurt (0.8 g n-3-LC-PUFA/125 g yoghurt) had a favourable effect on cardiovascular risk factors.
Keywords: long-chain multiply unsaturated fatty acids, omega-3-fatty acids, cardiovascular diseases, milk products, enrichment
Sie finden den Artikel in deutscher Sprache in Ernährungs Umschau 11/09 ab Seite 618.
Christine Dawczynski, Gerhard Jahreis, Jena
In two interventional studies in man, the influence of the consumption of n-3-LC-PUFA-enriched yoghurt was examined on cardiovascular risk factors . The volunteers consumed the intervention products with 0.8 g n-3-LC-PUFA/125 g yoghurt or comparator products for a period of 5 or 10 weeks. Blood samples were taken at the start and end of each phase.As a consequence of the 5-week consumption of the enriched products, HDL-cholesterol was significantly increased and the LDL/HDL quotient was reduced. After 10 weeks, these effects were more marked in the group given 0.8 g n-3-LC-PUFA/125 g yoghurt. The favourable changes in HDL-cholesterol and in the LDL/HDL quotient were not found in subjects given low fat (less enriched) yoghurt over a period of 10 weeks.
There was a trend for TAG to be reduced in this group (p ≤ 0.1). Conclusion: Daily consumption of n-3-LC-PUFA-enriched yoghurt (0.8 g n-3-LC-PUFA/125 g yoghurt) had a favourable effect on cardiovascular risk factors.
Keywords: long-chain multiply unsaturated fatty acids, omega-3-fatty acids, cardiovascular diseases, milk products, enrichment
Sie finden den Artikel in deutscher Sprache in Ernährungs Umschau 11/09 ab Seite 618.
Prevention of Cardiovascular Diseases with Milk Products Supplemented with Long-Chain Omega-3-Fatty Acids
Christine Dawczynski, Gerhard Jahreis, Jena
In two interventional studies in man, the influence of the consumption of n-3-LC-PUFA-enriched yoghurt was examined on cardiovascular risk factors . The volunteers consumed the intervention products with 0.8 g n-3-LC-PUFA/125 g yoghurt or comparator products for a period of 5 or 10 weeks. Blood samples were taken at the start and end of each phase.
As a consequence of the 5-week consumption of the enriched products, HDL-cholesterol was significantly increased and the LDL/HDL quotient was reduced. After 10 weeks, these effects were more marked in the group given 0.8 g n-3-LC-PUFA/125 g yoghurt. The favourable changes in HDL-cholesterol and in the LDL/HDL quotient were not found in subjects given low fat (less enriched) yoghurt over a period of 10 weeks.
There was a trend for TAG to be reduced in this group (p ≤ 0.1). Conclusion: Daily consumption of n-3-LC-PUFA-enriched yoghurt (0.8 g n-3-LC-PUFA/125 g yoghurt) had a favourable effect on cardiovascular risk factors.
Keywords: long-chain multiply unsaturated fatty acids, omega-3-fatty acids, cardiovascular diseases, milk products, enrichment
Sie finden den Artikel in deutscher Sprache in Ernährungs Umschau 11/09 ab Seite 618.